| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9169226 | Heart Rhythm | 2005 | 8 Pages |
Abstract
Flecainide recovers its antiarrhythmic action after cardioversion of AF. However, successful pharmacologic cardioversion occurs only after SR has lasted at least 4 days and is expected only for recurrences having duration of a few hours. Immediate pharmacologic cardioversion of AF recurrence may be a worthwhile strategy for management of persistent AF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert G. MD, PhD, Isabelle C. MD, Hans A. MD, Tsjerk MSc, Arthur A.M. MD, Charles J.H.J. MD, Johan H. MD, Frank A.L.E. MD, Nic J.G.M. MSc, Jaap PhD, Maurits A. MD, PhD, Harry J.G.M. MD,